Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study.
Emily E NaoumAdam A DaliaRussel J RobertsLauren T DevineJamel P OrtolevaPublished in: BMC anesthesiology (2022)
In patients with refractory shock receiving MB, there is a non-statistically significant trend toward improved outcomes in responders based on a MAP increase >10%. Patients supported with CRRT who were identified as responders had decreased ICU mortality compared to non-responders.